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A N A T O M I C A L P A T H O L O G Y
Haemosiderosis in the placenta does not appear to be related to chronic
placental separation or adverse neonatal outcome
T. Y. KHONG*, T. J. TOERING*{ AND J. J. H. M. ERWICH{
*SA Pathology, Women’s and Children’s Hospital, Adelaide, South Australia; {Department of Obstetrics,
University Medical Centre Groningen, Groningen, The Netherlands
Summary
Aims: To ascertain the incidence and to review the obstetric
and neonatal correlates of placental haemosiderosis. Sec-
ondly, to determine if placental haemosiderosis is due to
blood contamination during placental handling.
Methods: One hundred consecutive singleton placentas with
and 113 consecutive singleton placentas from uncomplicated
pregnancies without an indication for pathological examina-
tion were stained for iron to detect haemosiderosis in the
membranes, chorionic plate and/or basal plate. The obstetric
and neonatal data were analysed. In the second part,
maternal retroplacental blood was placed on the chorionic
plates of 15 placentas for 1, 3, 4 and 5 days prior to sampling
and examination for iron deposition.
Results: Haemosiderosis was observed in 110 of 213
(51.6%) placentas. Early decelerations during fetal heart rate
monitoring (p¼ 0.0498) and, negatively, maternal thrombo-
philia (p¼ 0.0496) were related to haemosiderosis in the
placenta. Preterm delivery, chronic separation of the placenta
or procedures performed during pregnancy or delivery were
not significantly related to haemosiderosis. Different patterns
of iron staining were observed but these were not correlated
with any maternal or neonatal factors. In the experimental
study, haemosiderin was not found in sections taken at
various time intervals from both blood contaminated and
blood contamination-free parts of the placentas.
Conclusions: Haemosiderosis in the placenta is not an artefact
of placental handling. Haemosiderosis is seen considerably
more frequently than previously reported and may be
physiological. Haemosiderosis is not a useful indicator for
chronic placental abruption and adverse neonatal outcome is
not significantly correlated with placental haemosiderosis.
Key words: Placenta, haemosiderin, chronic abruption, neonatal outcome.
Received 13 July, revised 27 August, accepted 28 August 2009
INTRODUCTION
Iron pigment staining in the membranes and in the chorionic
plate of the placenta, deﬁned as diﬀuse chorioamnionic
haemosiderosis (DCH), has been described as an objective
marker of chronic placental separation. Redline andWilson-
Costello found that placentas with DCHwere more likely to
show circumvallation, old peripheral blood clots, increased
chorionic-villous macrophages, and green discolouration.
Multiparity, smoking, and chronic vaginal bleeding were all
signiﬁcantly associated with DCH, while the incidence of
intrauterine growth restriction and oligohydramnios were
increased but did not achieve statistical signiﬁcance.1
Another study found that placentas with DCH were more
likely to show old peripheral blood clots, marginal
haematoma and circumvallation. Amniotic necrosis was
signiﬁcantly more frequent in the DCH group and the
incidence of recurrent episodes of vaginal bleeding, oligohy-
dramnios and chronic abruption syndrome were signiﬁ-
cantly higher in the DCH group. This study also found that
DCH was closely associated with preterm delivery, pulmon-
ary hypertension of the newborn and dry lung syndrome and
was a signiﬁcant risk factor for chronic lung disease.2
The purpose of our study was to reassess the obstetric and
neonatal correlates of haemosiderin-laden macrophages in
the chorionic and/or basal plate of the placenta and
membranes. Secondly, we wished to investigate whether
iron deposition in the chorionic plate andmembranes can be
due to an artefact of placental handling. The rationale for
the second part of the study was predicated by the anatomy
of the placenta in relation to its separation. The presence of
haemosiderin-laden macrophages diﬀusely distributed
through the amniochorial membranes and chorionic plate,
i.e., the fetal side of the placenta, is counter-intuitive to
retroplacental haemorrhage occurring on the maternal side
of the placenta where focal haemosiderin-laden macro-
phages would be expected to be seen in the placental basal
plate in the area of accumulated blood at the site of placental
separation from the uterus.
MATERIALS AND METHODS
Case review
Two groups of placentas were used for this study. The ﬁrst group, the
pathological examination-indicated, comprised 100 consecutive singleton
placentas submitted for pathological examination because of one or more
indications according to the College of American Pathologists’ guidelines3
over a 2-month period from December 2006 to January 2007. The second
group, the non-pathological examination-indicated, comprised 113 single-
ton placentas that did not have indications for pathological examination
from placentas consecutively collected from all pregnancies during June
1998. Collection and processing of placentas were similar over the two time
periods. All placentas were processed using a standard protocol. A full
thickness cross-section of the placenta and a section of the amniochorial
membranes were cut at 4 mm and stained for haemosiderin with the Perls’
Prussian Blue technique.
All sections were evaluated for the presence of haemosiderin using light
microscopy blinded to clinical data (by two authors, TJT and TYK).
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Where present, the site of haemosiderin deposition was noted for each case:
chorionic plate, basal plate or membranes; the last was further qualiﬁed to the
amniotic, chorionic layer or decidual layer, or in a combination of the layers.
Haemosiderin deposition in the membrane roll sections were graded as mild,
moderate or severe, based on the extent and the density of the haemosiderin
deposition. The extent of the haemosiderosis was classiﬁed as diﬀuse when
haemosiderin deposition existed in ﬁve or more adjacent high power ﬁelds
(HPF;620 objective lens), or as localisedwhenhaemosiderin occurred in fewer
than ﬁve adjacent HPF. The density of the haemosiderosis was deﬁned as high
when there were 10 or more haemosiderin-laden macrophages in one HPF
(620 objective lens), or as low when there were fewer than 10 haemosiderin-
laden macrophages. Membrane roll sections with a localised and low density
haemosiderosis were graded asmild haemosiderosis; sections with a diﬀuse and
high density haemosiderosis were graded as severe haemosiderosis; the rest of
the haemosiderin-positive membrane-sections were graded as moderate
haemosiderosis. This grading was done for each layer of the membranes by
two authors (TJT, TYK) and diﬀerences in grading were resolved by double-
headed microscopy review.
Obstetric complications, procedures done during pregnancy or
delivery and clinical factors of mother and fetus, which might
correlate with placental haemosiderosis, were reviewed from the hospital
Clinical Information Services database containing pregnancy and
outcome details of every live birth and late fetal death delivered in the
hospital. The following clinical data were analysed.
Obstetric complications in current or previous pregnancy were: polyhy-
dramnios, deﬁned as 48 cm of the largest vertical amniotic ﬂuid pocket by
ultrasonography or above 25 cm of amniotic ﬂuid index (AFI); oligohydram-
nios, deﬁned as52 cm of the largest vertical amniotic ﬂuid pocket by
ultrasonography or below 5 cm of AFI; preterm prelabour rupture of
membranes (PPROM), deﬁned as clinically conﬁrmed rupture of membranes
before the onset of uterine contractions at a gestational age below 37 weeks;
premature labour, deﬁned as labour before 37 completed weeks of gestation;
abruption of the placenta, deﬁned as clinically conﬁrmed premature separation
of a normally implanted placentaprior todelivery; chorioamnionitis, deﬁned as
the presence of maternal fever of greater than 388C and at least two of the
following conditions: maternal leukocytosis (415 000 cells mm73), maternal
tachycardia (4100 beats/min), fetal tachycardia (4160 beats/min), uterine
tenderness, foul odour of the amniotic ﬂuid; placenta praevia, deﬁned as the
presence of placental tissue overlying or proximate to the internal cervical os by
ultrasonography; gestational hypertension, deﬁned as a systolic blood pressure
l40 mmHg or diastolic blood pressure 90 mmHg in a woman who was
normotensive prior to 20 weeks of gestation; pre-eclampsia, deﬁned as pre-
existing hypertension with new onset of proteinuria (0.3 g protein in a
24 h urine specimen) after 20 weeks of gestation and an exacerbation of
blood pressure to the severe range (systolic l60 mmHg or diastolic
110 mmHg) in the last half of pregnancy; intrauterine growth restriction
(IUGR), deﬁned as birth weight 510th percentile expected for gestational
age; elective and/or emergent caesarean section.
Procedures done during pregnancy or delivery, which might lead to intra-
amniotic bleeding were: umbilical cord blood sampling; intrauterine fetal
transfusion; amniocentesis; chorionic villous sampling; fetal scalp blood
monitoring.
Clinical factors of the mother were: tobacco use during pregnancy;
tobacco use before pregnancy, but not during pregnancy; age520 years
and434 years; gravida (G4 0); grand multiparity (P4 5); maternal
thrombophilia; previous stillbirth.
Clinical factors of the baby were: sex; fetal distress; fetal monitoring
abnormalities including: early deceleration, late deceleration, variable
deceleration, reduced variability, bradycardia and tachycardia; meconium
stained liquor (MSL); low Apgar score at 1 min and 5 min (0–3 was deﬁned
as critically low, 4–7 was deﬁned as fairly low); admission into neonatal
intensive care unit (NICU); congenital abnormalities in general and
gastrointestinal tract abnormalities in particular.4
Statistical analysis
The data of the two groups, haemosiderin positive cases and haemosiderin
negative cases, were analysed for diﬀerences using the w2 analysis or Fisher
exact tests. A p value  0.05 was considered statistically signiﬁcant.
Experimental study
Fifteen singleton term placentas, with intact membranes, from uncompli-
cated pregnancies were randomly collected and processed within 30 min
after delivery. Upon receipt of the placenta from the delivery room (day 0)
a cross-section of the chorionic plate was taken and ﬁxed immediately in
formalin, processed routinely and subsequently stained with Perls’ stain.
The placenta was subsequently included in the experiment when no
haemosiderin was found in this cross-section of the chorionic plate.
After taking the test section, the placenta was divided into two parts.
One half of the placenta was rinsed brieﬂy with water to ensure that the
chorionic plate was not in contact with fetal or maternal blood. To simulate
contamination of the fetal surface of the placenta by blood spilling from an
avulsed or cut end of the umbilical cord or from maternal blood, blood
obtained from the umbilical cord was placed on the surface of the chorionic
plate of the other half of the placenta. Both halves of placentas were placed
in separate closed buckets at room temperature (218C) for the ﬁrst 24 h as
macrophages are less active at lower temperatures.5 After 24 hours (day 1)
another cross-section of the chorionic plate was taken from each half of the
placenta (with blood contact and without blood contact). These sections
were also ﬁxed in formalin, processed as described above and stained for
haemosiderin with Perls’ staining. To simulate any potential delay in
delivery-to-ﬁxation of the placenta, and in accordance with the normal
work routine, the two halves of the placenta were then placed in separate
closed buckets at 48C to prevent autolysis of the placenta: ﬁve placentas
were kept in the fridge for 48 h (until day 3), ﬁve for 72 h (until day 4) and
the remaining ﬁve for 96 h (until day 5), at which point the last cross-
section of the chorionic plate was taken from the two halves of the
placenta. These sections were ﬁxed in formalin, processed as described
above and stained for haemosiderin with Perls’ staining and sections of the
placentas were evaluated for haemosiderosis in the chorionic plate using the
same criteria as those speciﬁed above.
RESULTS
Case review
Iron stain positive pigment deposition (haemosiderosis)
was found in 110 of the 213 placentas examined (51.6% of
all placentas). The incidence was 49.0% in the pathological
examination-indicated group (49/100) and 54.0% in the
non-pathological examination-indicated group (61/113).
Haemosiderosis was seen in the membranes and/or
chorionic plate and/or basal plate in various combinations
(detailed data available from authors).
Haemosiderosis was seen most frequently (103/110;
93.6%) in the extraplacental membranes. Within this group
of 103 haemosiderin-positive membranes, it was most
frequently seen in the chorionic layer (89/103); it was seen
only in the chorionic layer of the membranes and not other
locations simultaneously in 41 cases and in combination
with haemosiderosis in the chorionic and/or basal plates in
10 cases. In 35 cases (34.0%) haemosiderosis was found in
the chorionic and decidual layers but not in the amniotic
layer.
Haemosiderin was seen in the chorionic plate in 18 cases
(16.4%); in only ﬁve cases was haemosiderosis present in
the chorionic plate but not at other locations. Haemosider-
in was seen in the basal plate of the placenta in 18 cases
(16.4%); in one case it was seen only in the basal plate but
not at other locations. In one case it was seen simulta-
neously in the chorionic and basal plates. Thus, in the
majority of cases where haemosiderosis was detected in the
chorionic plate and/or basal plate, haemosiderosis was seen
also in the membranes.
The extent and density of the haemosiderin deposition
within the membranes varied between the three layers.
















































Based on the highest grade in the three layers of the
membranes, haemosiderosis was mild in 54 cases (52.4%),
moderate in 32 (31.1%), and severe in 17 (16.5%) (detailed
data available from authors) (Fig. 1).
Three diﬀerent patterns of haemosiderosis were distin-
guished: a cluster of blue spots, a blue ring around a cell
and a dark blue big spot (Fig. 2). Two or all three patterns
were seen in most cases (Table 1).
Clinical features of haemosiderosis
No signiﬁcant relation was found between any of the
obstetric complications and the presence of haemosiderosis
(Table 2). There were no cases with abruption of the
placenta or chorioamnionitis.
No signiﬁcant relation was found between obstetric
procedures and the occurrence of haemosiderosis. The
majority of cases who had amniocentesis (12 versus 6;
p¼ 0.27) or fetal scalp blood sampling (11 versus 3;
p¼ 0.48) had haemosiderosis. There was one case with
chorionic villous sampling, which did not have haemosi-
derosis. Fetal blood sampling and intrauterine transfusion
was not performed in any of the 213 cases.
Haemosiderosis in the placenta was not related to
maternal age, gravidity, parity, smoking or previous
miscarriage or stillbirth. Placental haemosiderosis was not
related to sex of the baby, low Apgar score or congenital
abnormalities (Table 3). There was no correlation between
haemosiderosis and gestational age: in the non-pathology
Fig. 1 Haemosiderosis in the membranes, demonstrating (a) mild, (b)
moderate and (c) severe grades.
Fig. 2 Deposition of iron as (a) a clustered stippling of blue dots; (b) a

















































indicated group, the median gestational age of the
haemosiderosis positive group was 40 (range 34–42)
weeks and of the haemosiderosis negative group was 39
(range 38–41) weeks; in the pathology indicated group,
eight of 51 haemosiderosis negative placentas and 10 of
49 haemosiderosis positive placentas were 532 weeks
(p¼ 0.54). Haemosiderosis occurred signiﬁcantly less
frequently in cases with thrombophilia (p¼ 0.0496), but
the numbers were small. It was related to the observation
of early decelerations during fetal heart rate monitoring
(15 haemosiderin positive versus 5 haemosiderin negative;
p¼ 0.0498). Other fetal heart rate abnormalities (late
deceleration, variable deceleration, reduced variability,
bradycardia, and tachycardia) were not signiﬁcantly
related to haemosiderosis. The majority of the cases
with fetal distress (17/26; 65%) showed haemosiderosis in
the placenta, but this was not signiﬁcant. None of the
babies was admitted to the neonatal intensive care unit
(NICU).
No correlation was found between the obstetric and
neonatal correlates and the grade, extent of haemosiderosis,
density or pattern of haemosiderin staining.
Experiment
Haemosiderin was not found in any of the sections taken at
various time intervals from both the blood contaminated
and blood contamination-free halves of the placenta.
DISCUSSION
In this study we found haemosiderosis in the membranes
and/or chorionic plate and/or basal plate in 51.6% (110/
213) placentas examined. This ﬁgure was not signiﬁcantly
diﬀerent between those 100 placentas that had an indica-
tion for pathological examination and those 113 that did
not. Previous studies on diﬀuse chorioamniotic haemosi-
derosis had considerably lower incidences.1,2,6 Redline and
Wilson-Costello found an incidence of 2.2% (23/1023)1
while Ohyama et al. found an incidence of 4.2% (46/1100).2
In both of these groups there were indications for placental
examinations but, even so, the incidence in our pathological
examination-indicated placentas was 49/100. In a study on
prematurity, decidual haemosiderosis was seen in 43%
(196/462) preterm, which the authors deﬁned as532 weeks
gestation, but in only 0.8% (1/108) term placentas.6
Table 1 Pattern of haemosiderosis and topography
Cluster of blue spots Blue halo ring Large dark blue spot
No. of cases n % n % n %
Amniotic layer of membranes 7 5 71.4 4 57.1 0 0.0
Chorionic layer of membranes 89 88 98.9 21 23.6 4 4.5
Decidual layer of membranes 49 27 55.1 35 71.4 9 18.4
Chorionic plate 18 11 61.1 4 22.2 13 72.2
Basal plate 18 15 88.3 8 44.4 18 100.0
Table 2 Correlation of obstetric complications and positive haemosiderin deposition in membranes, chorionic plate and/or basal plate of the placenta
Haemosiderin positive Haemosiderin negative
No. of cases n % n % p value
Polyhydramnios 3 2 66.7 1 33.3 0.5248*
Oligohydramnios 1 1 100.0 0 0.0 0.5164*
Vaginal bleeding 12 5 41.7 7 58.3 0.6784
PPROM 30 16 53.3 14 46.7 0.9987
Previous PPROM 0{ – – –
Premature labour 52 28 53.8 24 46.2 0.7146
Previous premature labour 15{ 6 40.0 9 60.0 0.6049
Abruption of placenta 0 – – –
Previous abruption of placenta 5{ 3 60.0 2 40.0 0.4928*
Chorioamnionitis 0 – – –
Placenta previa 4 2 50.0 2 ‘50.0 0.6641*
Gestational hypertension 3 0 0.0 3 100.0 0.1114*
Preeclampsia (moderate and severe) 19 12 63.0 7 37.0 0.4169
IUGR 14 7 50.0 7 50.0 0.8813
Previous IUGR 1{ 1 100.0 0 0.0 0.4962
Caesarean section, elective or emergent 73 40 54.8 33 45.2 0.6030
Caesarean section (emergent) 54 32 59.3 22 41.7 0.2549
Previous caesarean section 23{ 12 52.2 11 47.8 0.9684
*Based on one-tailed Fisher’s exact test.
{Only multigravid patients: haemosiderin positive (n¼ 66), haemosiderin negative (n¼ 67).
IUGR, intrauterine growth restriction; PPROM, preterm premature rupture of the membranes.
















































Given this marked diﬀerence in the incidences, ﬁrstly, we
established that haemosiderosis was not an artefact of
placental handling prior to placental sampling and proces-
sing. We then asked whether there were diﬀerences in the
study designs. While our study included the basal plate,
there was only one case in which haemosiderosis was seen
solely in the basal plate but not concurrently in either the
chorionic plate or membranes. Thus, our incidence of
haemosiderosis in only membranes and/or chorionic plate,
as in the design of the other two studies,1,2 is still
signiﬁcantly greater than those observed by the previous
investigators. Our choice of Perls’ Prussian Blue stain for
detecting iron compared with Gomori and Berlin Blue, as
used by the other groups, is unlikely to explain the
diﬀerence since the other two methods are variants of the
Perls’ stain. It is probable that selection of cases could
account for some of the diﬀerence. Although those studies
had seemingly large sample sizes, the selection of the cases
excluded examination of many of those placentas for
haemosiderosis.1,2 In the former study, from 1023 placen-
tas, 206 had pigment, of which 170 were excluded because
of a history of meconium staining or a histological ﬁnding
‘suggestive of meconium’ and, thus, iron staining was only
performed for 36 placentas.1 This is signiﬁcant as the
diﬀerentiation between meconium and iron pigment on
light microscopy alone can be extremely diﬃcult.7–10 In the
latter study, the method infers that iron staining was
performed following light microscopy determination of
pigment in the membranes and chorionic plate.2 In our
study, we non-selectively applied the iron staining to one
section of the membranes and one full thickness that
included the basal plate and chorionic plate of all the
placentas blinded to the naked eye appearance, clinical
history or initial light microscopic evaluation.
We did not ﬁnd haemosiderosis in the membranes,
chorionic plate and/or basal plate of the placenta to be
associated with maternal and/or fetal clinical factors of
chronic separation of the placenta or with preterm birth.
We are at a loss to explain the association between early
decelerations during fetal heart rate monitoring and
haemosiderosis, which was just statistically signiﬁcant as
was the negative correlation with thrombophilia; there was
no signiﬁcant relationship between fetal distress and
haemosiderosis. Procedures that may lead to leakage of
blood into the amniotic ﬂuid might be anticipated to be
related to haemosiderosis in the amniotic and chorionic
layer of the membranes and/or chorionic plate. Although
haemosiderosis was found more frequently in cases where
either amniocentesis or fetal scalp blood sampling had been
performed, this was not signiﬁcant; umbilical blood
sampling or intrauterine transfusion was not performed in
any of the pregnancies studied.
Table 3 Correlation of maternal and fetal clinical factors and positive haemosiderin deposition in membranes, chorionic plate and/or basal plate of the
placenta
Haemosiderin positive Haemosiderin negative
Clinical factors No. of cases n % n % p value
Mother
Age (years)
520 14 8 57.1 6 42.9 0.8813
434 45 23 51.1 22 48.9 0.9303
Primigravida 80 44 55.0 36 45.0 0.5361
Grand multiparous (P5) 2 1 50.0 1 50.0 0.7345*
Smoking (prior and/or during pregnancy) 47{ 22 46.8 25 53.2 0.5579
Thrombophilia 7 1 14.3 6 85.7 0.0496*
Previous stillbirth 4{ 3 75.0 1 25.0 0.3359
Previous miscarriage 50{ 25 50.0 25 50.0 0.9171
Baby
Male sex 106 50 47.2 56 52.8 0.2755
Fetal distress 26 17 65.4 9 34.6 0.2073
Monitoring abnormalities 73 41 56.2 32 43.8 0.4185
Early deceleration 20 15 66.7 5 33.3 0.0498
Late deceleration 10 5 50.0 5 50.0 0.5842*
Variable deceleration 40 22 55.0 18 45.0 0.7673
Reduced variability 14 9 64.3 5 35.7 0.4823
Bradycardia 14 7 50.0 7 50.0 0.8813
Tachycardia 14 6 42.9 8 57.1 0.6863
Meconium stained liquor 23 16 69.6 7 30.4 0.1095
Apgar score 0–3
At 1 min 3 1 33.3 2 66.7 0.4752*
At 5 min 0 – –
Apgar score 4–7
At 1 min 51 27 52.9 24 47.1 0.9585
At 5 min 9 3 33.3 6 66.7 0.2176*
Congenital abnormalities 9x 3 33.3 6 66.7 0.2176*
In gastrointestinal tract 1 0 0.0 1 100.0 0.4836*
Admission into NICU 0 – – –
*Based on one-tailed Fisher’s exact test.
{Ten cases were unknown: ﬁve were haemosiderin positive and ﬁve were haemosiderin negative.
{Only multigravid patients: 66 were haemosiderin positive, 67 were haemosiderin negative.
xSixteen cases were unknown: seven were haemosiderin positive and nine were haemosiderin negative.

















































A diﬃculty with the concept of diﬀuse chorioamniotic
haemosiderosis is that the term ‘diﬀuse’ was not deﬁned;1,2
the absence of a deﬁnition of diﬀuse and whether localised
lesions were diﬀerentiated and excluded in other studies
could also account for the diﬀerence in the incidence
between those studies and the current study. This diﬃculty
is further compounded by an attempt to quantify the
magnitude into categories of mild, moderate or severe.1,2
Salaﬁa et al. sorted placentas into either having haemosi-
derosis or not,6 an approach which we also took. In
quantifying haemosiderosis, we used objective criteria to
deﬁne extent and density of the haemosiderin deposition.
Using our deﬁnition, diﬀuse haemosiderosis was not
correlated with any of the obstetric or neonatal character-
istics. Furthermore, the pattern of staining did not appear
to correlate with the obstetric or neonatal characteristics.
The reasons for the diﬀerent patterns of haemosiderin
staining are unclear to us.
The distribution of iron staining within the membranes
could have provided an insight as to the source of blood
and haemosiderin. It could be speculated that where there
was iron in the decidual or in the decidual and chorionic
layers of the membranes, the direction of haemosiderin
uptake in the membranes was from the decidual layer
towards the amniotic cavity, and where there was iron in
the amniotic or in the amniotic and chorionic layers of the
membranes, the direction of haemosiderin uptake in the
membranes could be from the amniotic layer towards
the decidua. However, the results did not provide any
conclusive insight into this direction and, indeed, the
majority of haemosiderin positive membranes had haemo-
siderosis only in the chorionic layer. We suggest that a
possible source of the haemosiderin could be explained by
the embryology of the amniochorial membranes: prior to
the fusion of the decidua capsularis with the decidua
parietalis, the maternal vessels in the decidua capsularis
contain blood and this blood supply becomes attenuated
with enlargement of the chorionic sac, resulting in the
creation of the smooth chorion laeve and fusion of the
decidua capsularis with the decidua parietalis. Therefore,
whether there is haemosiderin within the amniochorial
membranes at delivery could be dependent on the amount
of residua of blood within the chorion capsularis and
decidua capsularis. The sources of haemosiderin in the
chorionic plate and basal plate are likely to be retro-
placental haemorrhage and intra-amniotic bleeding, respec-
tively.
The lesion of placental haemosiderosis is poorly elabo-
rated in the standard books of placental pathology7–10
which quote the association with circumvallate placenta-
tion,7–10 chronic haematoma8,9 and intrauterine growth
restriction.8 It has also been found to be one of several
placental lesions signiﬁcantly associated with cerebral palsy
and neurological impairment following term delivery.11
Since placental examination is pivotal in medical legal
cases, especially with regard to cerebral palsy and
neurological impairment,12 it was imperative that a critical
re-examination of the clinico-pathological correlations and
incidence of the lesion be performed. In conclusion, the
incidence is markedly higher than previously reported and
haemosiderosis is seen as frequently in placentas without an
indication for pathological examination. However, haemo-
siderosis in the placenta is not due to an artefact of
placental handling and we have not found it to be
associated with chronic peripheral separation of the
placenta or with adverse neonatal outcome. It is likely that
haemosiderosis in the amniochorial membranes is physio-
logical in the majority of cases. It remains to be determined
which placentas displaying haemosiderosis have pathologi-
cal causes for this.
Address for correspondence: Professor T. Y. Khong, SA Pathology,
Women’s and Children’s Hospital, 72 King William Road, North
Adelaide, SA 5006, Australia. E-mail: yee.khong@adelaide.edu.au
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